CIS-DIAMMINEDICHLOROPLATINUM II
Non-Small Cell Lung Cancer, Small Cell Lung Cancer
University of Maryland, BaltimoreSmall moleculePhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Non-Small Cell Lung Cancer, Small Cell Lung Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Kml-001 University of Maryland, Baltimore | Phase 1 | CC |
Same molecule, other indications
CIS-DIAMMINEDICHLOROPLATINUM II is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →